Michael Willmann

2.1k total citations
52 papers, 1.4k citations indexed

About

Michael Willmann is a scholar working on Immunology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael Willmann has authored 52 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 21 papers in Molecular Biology and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael Willmann's work include Veterinary Oncology Research (19 papers), Mast cells and histamine (19 papers) and Chronic Myeloid Leukemia Treatments (8 papers). Michael Willmann is often cited by papers focused on Veterinary Oncology Research (19 papers), Mast cells and histamine (19 papers) and Chronic Myeloid Leukemia Treatments (8 papers). Michael Willmann collaborates with scholars based in Austria, Germany and United States. Michael Willmann's co-authors include Peter Valent, Johann G. Thalhammer, M. Bürger, Wolfgang Henninger, Wolfgang R. Sperr, Matthias Mayerhofer, Thomas Rülicke, Emir Hadzijusufovic, Gabriele Stefanzl and Gregor Hoermann and has published in prestigious journals such as Blood, Clinical Cancer Research and American Journal Of Pathology.

In The Last Decade

Michael Willmann

51 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Willmann Austria 20 391 374 370 277 249 52 1.4k
Christof Iking‐Konert Germany 23 282 0.7× 333 0.9× 811 2.2× 176 0.6× 148 0.6× 67 1.8k
R M O'Hara United States 13 274 0.7× 104 0.3× 885 2.4× 159 0.6× 336 1.3× 24 1.5k
Jessica Lawrence United States 20 317 0.8× 605 1.6× 167 0.5× 44 0.2× 157 0.6× 77 1.2k
Ellen J. Beswick United States 27 326 0.8× 165 0.4× 951 2.6× 51 0.2× 500 2.0× 53 1.8k
Kazuyuki Matsuda Japan 22 498 1.3× 126 0.3× 425 1.1× 370 1.3× 359 1.4× 114 1.6k
William C. Kisseberth United States 30 863 2.2× 1.3k 3.6× 388 1.0× 67 0.2× 519 2.1× 79 2.5k
Sylvie Caulet-Maugendre France 19 220 0.6× 331 0.9× 427 1.2× 61 0.2× 474 1.9× 45 1.6k
Amanda Guth United States 19 322 0.8× 377 1.0× 799 2.2× 38 0.1× 284 1.1× 37 1.3k
Irene J. Check United States 22 242 0.6× 140 0.4× 515 1.4× 231 0.8× 174 0.7× 55 1.5k
Ryoji Ito Japan 23 547 1.4× 275 0.7× 1.0k 2.7× 253 0.9× 647 2.6× 102 2.1k

Countries citing papers authored by Michael Willmann

Since Specialization
Citations

This map shows the geographic impact of Michael Willmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Willmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Willmann more than expected).

Fields of papers citing papers by Michael Willmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Willmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Willmann. The network helps show where Michael Willmann may publish in the future.

Co-authorship network of co-authors of Michael Willmann

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Willmann. A scholar is included among the top collaborators of Michael Willmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Willmann. Michael Willmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Polyák, András, Nina Angrisani, Nina Ehlert, et al.. (2023). Preparation and PET/CT imaging of implant directed 68Ga-labeled magnetic nanoporous silica nanoparticles. Journal of Nanobiotechnology. 21(1). 270–270. 8 indexed citations
2.
Valent, Peter, Irina Sadovnik, Barbara Peter, et al.. (2023). Vienna Cancer Stem Cell Club (VCSCC): 20 year jubilee and future perspectives. Expert Review of Hematology. 16(9). 659–670.
3.
Stefanzl, Gabriele, Barbara Peter, Karin Bauer, et al.. (2019). Effects of ibrutinib on proliferation and histamine release in canine neoplastic mast cells. Veterinary and Comparative Oncology. 17(4). 553–561. 14 indexed citations
4.
Willmann, Michael, Emir Hadzijusufovic, Olivier Hermine, et al.. (2018). Comparative oncology: The paradigmatic example of canine and human mast cell neoplasms. Veterinary and Comparative Oncology. 17(1). 1–10. 17 indexed citations
5.
Singer, Josef, Judit Fazekas, Wei Wang, et al.. (2014). Generation of a Canine Anti-EGFR (ErbB-1) Antibody for Passive Immunotherapy in Dog Cancer Patients. Molecular Cancer Therapeutics. 13(7). 1777–1790. 41 indexed citations
6.
Blatt, Katharina, Harald Herrmann, Gregor Hoermann, et al.. (2014). Identification of Campath-1 (CD52) as Novel Drug Target in Neoplastic Stem Cells in 5q-Patients with MDS and AML. Clinical Cancer Research. 20(13). 3589–3602. 23 indexed citations
7.
Herrmann, Harald, Irina Sadovnik, Sabine Cerny‐Reiterer, et al.. (2014). Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia. Blood. 123(25). 3951–3962. 166 indexed citations
8.
Höller, Ulrich, et al.. (2013). Blood vitamin levels in dogs with chronic liver disease.. Wiener Tierarztliche Monatsschrift. 100. 133–139. 2 indexed citations
9.
Hadzijusufovic, Emir, Barbara Peter, Harald Herrmann, et al.. (2012). NI‐1: a novel canine mastocytoma model for studying drug resistance and IgER‐dependent mast cell activation. Allergy. 67(7). 858–868. 18 indexed citations
10.
Herrmann, Harald, Michael Kneidinger, Sabine Cerny‐Reiterer, et al.. (2012). The Hsp32 Inhibitors SMA-ZnPP and PEG-ZnPP Exert Major Growth-Inhibitory Effects on D34+/CD38+ and CD34+/CD38- AML Progenitor Cells. Current Cancer Drug Targets. 12(1). 51–63. 26 indexed citations
11.
Höller, Ulrich, et al.. (2011). Blood vitamin levels in dogs with chronic kidney disease. The Veterinary Journal. 192(2). 226–231. 33 indexed citations
12.
Peter, Barbara, Karoline V. Gleixner, Sabine Cerny‐Reiterer, et al.. (2011). Polo-like kinase-1 as a novel target in neoplastic mast cells: demonstration of growth-inhibitory effects of small interfering RNA and the Polo-like kinase-1 targeting drug BI 2536. Haematologica. 96(5). 672–680. 12 indexed citations
13.
Peter, Barbara, Emir Hadzijusufovic, Katharina Blatt, et al.. (2010). KIT polymorphisms and mutations determine responses of neoplastic mast cells to bafetinib (INNO-406). Experimental Hematology. 38(9). 782–791. 10 indexed citations
14.
Hadzijusufovic, Emir, Barbara Peter, Christian Baumgärtner, et al.. (2009). Growth-inhibitory effects of four tyrosine kinase inhibitors on neoplastic feline mast cells exhibiting a Kit exon 8 ITD mutation. Veterinary Immunology and Immunopathology. 132(2-4). 243–250. 15 indexed citations
15.
Willmann, Michael, Volker Wacheck, Jonathan D. Buckley, et al.. (2009). Characterization of NVX‐207, a novel betulinic acid‐derived anti‐cancer compound. European Journal of Clinical Investigation. 39(5). 384–394. 45 indexed citations
16.
Gerner, Wilhelm, Michael Willmann, Alexander Tichy, et al.. (2009). Effect of radiation on vascular endothelial growth factor expression in the C2 canine mastocytoma cell line. American Journal of Veterinary Research. 70(9). 1141–1150. 6 indexed citations
17.
Affenzeller, Nadja, Thomas Benesch, Johann G. Thalhammer, & Michael Willmann. (2009). A pilot study to evaluate a novel subcutaneous continuous glucose monitoring system in healthy Beagle dogs. The Veterinary Journal. 184(1). 105–110. 13 indexed citations
18.
Füreder, Wolfgang, Maria‐Theresa Krauth, Wolfgang R. Sperr, et al.. (2006). Evaluation of Angiogenesis and Vascular Endothelial Growth Factor Expression in the Bone Marrow of Patients with Aplastic Anemia. American Journal Of Pathology. 168(1). 123–130. 41 indexed citations
19.
Henninger, Wolfgang, et al.. (2003). CT FEATURES OF ALVEOLITIS AND SINUSITIS IN HORSES. Veterinary Radiology & Ultrasound. 44(3). 269–276. 87 indexed citations
20.
Bürger, M., et al.. (1997). Measurement of the pregnant cervix by transvaginal sonography: an interobserver study and new standards to improve the interobserver variability. Ultrasound in Obstetrics and Gynecology. 9(3). 188–193. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christof Iking‐Konert Breakdown of academic impact, for papers by R M O'Hara Breakdown of academic impact, for papers by Jessica Lawrence Breakdown of academic impact, for papers by Ellen J. Beswick Breakdown of academic impact, for papers by Kazuyuki Matsuda Breakdown of academic impact, for papers by William C. Kisseberth Breakdown of academic impact, for papers by Sylvie Caulet-Maugendre Breakdown of academic impact, for papers by Amanda Guth Breakdown of academic impact, for papers by Irene J. Check Breakdown of academic impact, for papers by Ryoji Ito
Rankless by CCL
2026